Sean D Sullivan

Summary

Publications

  1. ncbi request reprint Design, implementation, and first-year outcomes of a value-based drug formulary
    Sean D Sullivan
    University of Washington, 1959 N E Pacific Ave, Seattle, WA 98196
    J Manag Care Spec Pharm 21:269-75. 2015
  2. doi request reprint Comparative effectiveness research in the United States: a progress report
    Sean D Sullivan
    Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, 1959 NE Pacific Ave, Seattle, WA 98195 7630, USA
    J Med Econ 16:295-7. 2013
  3. pmc Prescriber and staff perceptions of an electronic prescribing system in primary care: a qualitative assessment
    Emily Beth Devine
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195 7630, USA
    BMC Med Inform Decis Mak 10:72. 2010
  4. ncbi request reprint A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitus
    Sean D Sullivan
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195, USA
    Pharmacotherapy 29:1280-8. 2009
  5. pmc Study protocol: the Back Pain Outcomes using Longitudinal Data (BOLD) registry
    Jeffrey G Jarvik
    Department of Radiology, University of Washington, Seattle, WA, USA
    BMC Musculoskelet Disord 13:64. 2012
  6. doi request reprint HBeAg-negative chronic hepatitis B: cost-effectiveness of peginterferon alfa-2a compared to lamivudine in Taiwan
    David L Veenstra
    University of Washington, Seattle, WA, USA
    Value Health 11:131-8. 2008
  7. ncbi request reprint Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom
    David L Veenstra
    University of Washington, Seattle, Washington 98195, USA
    Eur J Gastroenterol Hepatol 19:631-8. 2007
  8. ncbi request reprint A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II)
    Sean D Sullivan
    Pharmaceutical Outcomes Research and Policy Program and Department of Pediatrics, University of Washington, Seattle, WA 98195, USA
    Arch Pediatr Adolesc Med 159:428-34. 2005
  9. ncbi request reprint Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan
    Sean D Sullivan
    University of Washington, Seattle, Washington 98195, USA
    J Gastroenterol Hepatol 22:1494-9. 2007
  10. pmc An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis
    Josh J Carlson
    Institute for Public Health Genetics, School of Public Health and Community Medicine, University of Washington, Washington 98195, USA
    J Gastroenterol Hepatol 24:786-91. 2009

Collaborators

Detail Information

Publications67

  1. ncbi request reprint Design, implementation, and first-year outcomes of a value-based drug formulary
    Sean D Sullivan
    University of Washington, 1959 N E Pacific Ave, Seattle, WA 98196
    J Manag Care Spec Pharm 21:269-75. 2015
    ..Concurrently, Premera increased copayments for existing tiers...
  2. doi request reprint Comparative effectiveness research in the United States: a progress report
    Sean D Sullivan
    Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, 1959 NE Pacific Ave, Seattle, WA 98195 7630, USA
    J Med Econ 16:295-7. 2013
    ..Expectations for CER are high and public and private investments are sizeable. This paper discussions the evolution of CER in the US and gives a brief report on its progress and challenges...
  3. pmc Prescriber and staff perceptions of an electronic prescribing system in primary care: a qualitative assessment
    Emily Beth Devine
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195 7630, USA
    BMC Med Inform Decis Mak 10:72. 2010
    ..We describe prescriber and staff perceptions of implementation of a CPOE system for medications (electronic- or e-prescribing system) in the ambulatory setting...
  4. ncbi request reprint A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitus
    Sean D Sullivan
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195, USA
    Pharmacotherapy 29:1280-8. 2009
    ..To project and compare long-term outcomes of morbidity and mortality, and costs of complications of type 2 diabetes mellitus from a randomized controlled trial of patients receiving liraglutide versus glimepiride monotherapy...
  5. pmc Study protocol: the Back Pain Outcomes using Longitudinal Data (BOLD) registry
    Jeffrey G Jarvik
    Department of Radiology, University of Washington, Seattle, WA, USA
    BMC Musculoskelet Disord 13:64. 2012
    ....
  6. doi request reprint HBeAg-negative chronic hepatitis B: cost-effectiveness of peginterferon alfa-2a compared to lamivudine in Taiwan
    David L Veenstra
    University of Washington, Seattle, WA, USA
    Value Health 11:131-8. 2008
    ..Our objective is to evaluate the incremental cost-effectiveness of 48 weeks of peginterferon alfa-2a compared to 48 weeks of lamivudine, from the perspective of the Taiwan Bureau of National Health Insurance...
  7. ncbi request reprint Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom
    David L Veenstra
    University of Washington, Seattle, Washington 98195, USA
    Eur J Gastroenterol Hepatol 19:631-8. 2007
    ..We assessed the clinical outcomes and costs, from the perspective of the UK National Health Service, of 48 weeks of peginterferon alpha-2a (40 kDa) vs. 4 years of lamivudine...
  8. ncbi request reprint A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II)
    Sean D Sullivan
    Pharmaceutical Outcomes Research and Policy Program and Department of Pediatrics, University of Washington, Seattle, WA 98195, USA
    Arch Pediatr Adolesc Med 159:428-34. 2005
    ....
  9. ncbi request reprint Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan
    Sean D Sullivan
    University of Washington, Seattle, Washington 98195, USA
    J Gastroenterol Hepatol 22:1494-9. 2007
    ....
  10. pmc An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis
    Josh J Carlson
    Institute for Public Health Genetics, School of Public Health and Community Medicine, University of Washington, Washington 98195, USA
    J Gastroenterol Hepatol 24:786-91. 2009
    ..To assess the clinical and economic outcomes of non-invasive testing strategies in the diagnosis of significant liver fibrosis (Metavir score >or= 2) compared with liver biopsy...
  11. ncbi request reprint Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B
    David L Veenstra
    Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, Washington 98195, USA
    Pharmacoeconomics 25:963-77. 2007
    ..Previous economic analyses have been limited by the lack of comparative clinical data for entecavir and lamivudine beyond 1-year duration and for salvage therapy...
  12. ncbi request reprint Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery
    Sean D Sullivan
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195, USA
    Value Health 9:68-76. 2006
    ..To evaluate the cost-effectiveness of fondaparinux relative to enoxaparin as prophylaxis against venous thromboembolism (VTE) in patients undergoing hip fracture surgery...
  13. ncbi request reprint A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery
    Sean D Sullivan
    Department of Pharmacy and Health Services, University of Washington, Seattle, Washington 98195, USA
    Pharmacoeconomics 22:605-20. 2004
    ..To determine the cost effectiveness of fondaparinux sodium compared with enoxaparin sodium for prophylaxis against venous thromboembolism in patients undergoing major orthopaedic surgery...
  14. pmc Study protocol- Lumbar Epidural steroid injections for Spinal Stenosis (LESS): a double-blind randomized controlled trial of epidural steroid injections for lumbar spinal stenosis among older adults
    Janna L Friedly
    Comparative Effectiveness, Cost and Outcomes Research Center, University of Washington, Seattle, USA
    BMC Musculoskelet Disord 13:48. 2012
    ....
  15. pmc Electronic prescribing at the point of care: a time-motion study in the primary care setting
    Emily Beth Devine
    Biomedical and Health Informatics, School of Medicine, University of Washington, Seattle, WA
    Health Serv Res 45:152-71. 2010
    ..Two primary aims were to compare prescribing time between (1) handwritten and electronic (e-) prescriptions and (2) e-prescriptions using differing hardware configurations...
  16. ncbi request reprint The economics of venous thromboembolism prophylaxis: a primer for clinicians
    Bruce L Davidson
    Pulmonary and Critical Care Medicine Division, Swedish Medical Center and University of Washington School of Medicine, 801 Broadway, Suite 915, Seattle, WA 98122, USA
    Chest 124:393S-396S. 2003
    ..It is possible to list the important safety and efficacy outcomes of prophylaxis, estimate their incidences and costs, and "model" comparisons of one modality vs another, in order to help decide whether one is preferable...
  17. doi request reprint BMI trajectories among the severely obese: results from an electronic medical record population
    Edwin S Wong
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington, USA
    Obesity (Silver Spring) 20:2107-12. 2012
    ..Our results also suggest that once the 35 BMI threshold is reached, individuals will continue to remain severely obese, especially at younger ages...
  18. doi request reprint Patients' experience and outcomes after laparoscopic adjustable gastric banding in Washington state
    Vincent W Lin
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington
    Surg Obes Relat Dis 9:701-5. 2013
    ..Our objective was to estimate the amount of postoperative weight loss, change in co-morbidity status, and complications after LAGB. The setting was LAGB surgical centers in Washington state...
  19. doi request reprint Health care use and primary prophylaxis with colony-stimulating factors
    Sean D Sullivan
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Value Health 14:247-52. 2011
    ..We examined health care use in conjunction with primary prophylaxis use of colony stimulating factors (CSF) during patients' initial course of chemotherapy...
  20. doi request reprint Colony-stimulating factor use and impact on febrile neutropenia among patients with newly diagnosed breast, colorectal, or non-small cell lung cancer who were receiving chemotherapy
    Jeannine S McCune
    Department of Pharmacy, University of Washington, Seattle, USA
    Pharmacotherapy 32:7-19. 2012
    ....
  21. doi request reprint Association of early imaging for back pain with clinical outcomes in older adults
    Jeffrey G Jarvik
    Department of Radiology, University of Washington, Seattle2Department of Neurological Surgery, University of Washington, Seattle3Department of Health Services, University of Washington, Seattle4Comparative Effectiveness, Cost and Outcomes Research Center
    JAMA 313:1143-53. 2015
    ..In contrast to the recommendations for younger adults, many guidelines allow for older adults with back pain to undergo imaging without waiting 4 to 6 weeks. However, early imaging may precipitate interventions that do not improve outcomes...
  22. doi request reprint Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy
    Scott D Ramsey
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center and University of Washington Department of Medicine, Seattle, WA 98109, USA
    Value Health 12:217-25. 2009
    ....
  23. ncbi request reprint The cost-effectiveness of the management of acute sinusitis
    Yoshimi Anzai
    Department of Radiology, University of Washington, Seattle 98195 7115, USA
    Am J Rhinol 21:444-51. 2007
    ..Sinusitis is a common medical disease with a tremendous economic impact on health care. Our objective was to determine the most cost-effective strategy for the management of acute sinusitis from the societal and payers' perspectives...
  24. ncbi request reprint Conventional radiography, rapid MR imaging, and conventional MR imaging for low back pain: activity-based costs and reimbursement
    Darryl T Gray
    Department of Pediatrics, School of Medicine, University of Washington, 146 N Canal St, Suite 300, Seattle, WA 98103, USA
    Radiology 227:669-80. 2003
    ..To incorporate personnel and equipment use time in an activity-based cost comparison of conventional radiography and conventional and rapid magnetic resonance (MR) imaging for low back pain (LBP)...
  25. ncbi request reprint Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supply
    Brian Custer
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, USA
    Med Decis Making 25:571-82. 2005
    ..However, as a result of increasingly stringent screening measures, one of the greatest threats may be an insufficient supply. The balance between safety and adequacy of the blood supply has not received enough attention...
  26. ncbi request reprint A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study
    Paula Lozano
    Center for Health Studies, Group Health Cooperative, 1730 Minor Avenue, Seattle, WA 98101, USA
    Arch Pediatr Adolesc Med 158:875-83. 2004
    ..Traditional primary care practice change approaches have not led to full implementation of national asthma guidelines...
  27. doi request reprint Bioequivalent antiepileptic drug switching and the risk of seizure-related events
    Ryan N Hansen
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, United States
    Epilepsy Res 106:237-43. 2013
    ..We investigated the association between A-rated switching of each class of currently available AED and emergent treatment for a seizure-related event...
  28. pmc The impact of accreditation on safety and cost of bariatric surgery
    Steve Kwon
    Surgical Outcomes Research Center in the Department of Surgery and the Department of Health Services, University of Washington, Seattle, Washington
    Surg Obes Relat Dis 9:617-22. 2013
    ..We used inpatient care data of those with employer-sponsored insurance plans across United States using the MarketScan Commercial Claims and Encounter Database (2003-2009)...
  29. pmc The use, safety and cost of bariatric surgery before and after Medicare's national coverage decision
    David R Flum
    University of Washington Schools of Medicine, Pharmacy and Public Health, Seattle, WA, USA
    Ann Surg 254:860-5. 2011
    ..To determine the impact of the Centers for Medicare and Medicaid Services' (CMS) bariatric surgery national coverage decision (NCD) on the use, safety, and cost of care CMS beneficiaries...
  30. pmc Examining the BMI-mortality relationship using fractional polynomials
    Edwin S Wong
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
    BMC Med Res Methodol 11:175. 2011
    ..This approach was then compared against other commonly used regression models...
  31. doi request reprint A forensic evaluation of the National Emphysema Treatment Trial using the expected value of information approach
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington 98109, USA
    Med Care 46:542-8. 2008
    ....
  32. doi request reprint Association between health-related quality of life and body mass after adjustable gastric banding: a nonlinear approach
    Vincent W Lin
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195, USA
    Value Health 16:823-9. 2013
    ..To estimate the relationship between health utilities and body mass index (BMI) among a cohort of obese patients who underwent laparoscopic adjustable gastric banding (LAGB)...
  33. doi request reprint A systematic review to assess comparative effectiveness studies in epidural steroid injections for lumbar spinal stenosis and to estimate reimbursement amounts
    Brian W Bresnahan
    Department of Radiology, University of Washington, Seattle, WA 98104 2499, USA
    PM R 5:705-14. 2013
    ..TYPE: Systematic review...
  34. doi request reprint Expenditures and health status among adults with back and neck problems
    Brook I Martin
    Department of Orthopaedics and Sports Medicine, University of Washington, Seattle, WA 98104, USA
    JAMA 299:656-64. 2008
    ..Back and neck problems are among the symptoms most commonly encountered in clinical practice. However, few studies have examined national trends in expenditures for back and neck problems or related these trends to health status measures...
  35. pmc A model for incorporating patient and stakeholder voices in a learning health care network: Washington State's Comparative Effectiveness Research Translation Network
    Emily Beth Devine
    Pharmaceutical Outcome Research and Policy Program, University of Washington, Seattle, WA, USA
    J Clin Epidemiol 66:S122-9. 2013
    ....
  36. pmc Back pain in seniors: the Back pain Outcomes using Longitudinal Data (BOLD) cohort baseline data
    Jeffrey G Jarvik
    Department of Radiology, University of Washington, 325 Ninth Ave, Box 359728, Seattle, WA 98104 2499, USA
    BMC Musculoskelet Disord 15:134. 2014
    ..Our goal was to describe how pain, function and health-related quality of life vary by demographic and geographic factors among seniors presenting to primary care providers with new episodes of care for back pain...
  37. doi request reprint Asthma control, cost and race: results from a national survey
    Laura S Gold
    Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA 98195 9455, USA
    J Asthma 50:783-90. 2013
    ....
  38. pmc The impact of e-prescribing on prescriber and staff time in ambulatory care clinics: a time motion study
    William Hollingworth
    Department of Radiology, University of Washington, 325 Ninth Avenue, Seattle, WA 98104 2499, USA
    J Am Med Inform Assoc 14:722-30. 2007
    ..4 minutes/hour; 0.0, 10.7 CI). E-prescribing was not associated with an increase in combined computer and writing time for prescribers. If carefully implemented, e-prescribing will not greatly disrupt workflow...
  39. doi request reprint Comparison of guideline-based control definitions and associations with outcomes in severe or difficult-to-treat asthma
    Jonathan D Campbell
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington 98195, USA
    Ann Allergy Asthma Immunol 101:474-81. 2008
    ..The National Asthma Education and Prevention Program put forth guidance on how to measure asthma control. This guidance is flexible regarding how the impairment component of control is assessed...
  40. pmc The impact of computerized provider order entry on medication errors in a multispecialty group practice
    Emily Beth Devine
    Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, Washington 98195 7630, USA
    J Am Med Inform Assoc 17:78-84. 2010
    ..The objective was to evaluate the effect of a basic, ambulatory CPOE system on medication errors and associated ADEs...
  41. pmc Oncology comparative effectiveness research: a multistakeholder perspective on principles for conduct and reporting
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Oncologist 18:760-7. 2013
    ..In discussing these concepts, we also touched upon the notion of whether cancer is special among health issues with regard to how evidence is generated and used. ..
  42. pmc Cost-effectiveness of lung volume reduction surgery
    Scott D Ramsey
    Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Proc Am Thorac Soc 5:406-11. 2008
    ....
  43. ncbi request reprint Rapid magnetic resonance imaging vs radiographs for patients with low back pain: a randomized controlled trial
    Jeffrey G Jarvik
    Department of Radiology, University of Washington, Seattle, Wash 98195, USA
    JAMA 289:2810-8. 2003
    ..However, whether rapid MRI scanning results in better patient outcomes than radiographic evaluation or a cost-effective alternative is unknown...
  44. pmc Headache-related health resource utilisation in chronic and episodic migraine across six countries
    Joanna C Sanderson
    Pharmaceutical Outcomes Research and Policy Program PORPP, University of Washington, Seattle, Washington, USA
    J Neurol Neurosurg Psychiatry 84:1309-17. 2013
    ..To describe headache-related health resource usage in chronic and episodic migraine across six countries...
  45. doi request reprint Cardiovascular events associated with ipratropium bromide in COPD
    Sarika S Ogale
    Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, WA, USA
    Chest 137:13-9. 2010
    ..We sought to examine the association between ipratropium bromide use and the risk of cardiovascular events (CVEs)...
  46. pmc Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence
    Jonathan D Campbell
    School of Pharmacy, University of Washington, Seattle, USA
    BMC Urol 9:18. 2009
    ..Our objective was to conduct a literature review and synthesis of published measures of treatment success for OAB with UUI interventions and to identify a treatment success outcome...
  47. doi request reprint Cost-effectiveness of bariatric surgical procedures for the treatment of severe obesity
    Bruce C M Wang
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, 1959 NE Pacific Ave, H375Q, Seattle, WA, 98195, USA
    Eur J Health Econ 15:253-63. 2014
    ..One-third of Americans are obese and an increasing number opt for bariatric surgery. This study estimates the cost-effectiveness of common bariatric surgical procedures from a healthcare system perspective...
  48. ncbi request reprint Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Am J Manag Care 12:197-202. 2006
    ....
  49. ncbi request reprint Updated evaluation of the cost-effectiveness of lung volume reduction surgery
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M3 B232, Seattle, WA 98109, USA
    Chest 131:823-32. 2007
    ..We present an updated analysis of cost-effectiveness with 1-year additional follow-up data...
  50. doi request reprint Mapping a patient-reported functional outcome measure to a utility measure for comparative effectiveness and economic evaluations in older adults with low back pain
    Sean D Rundell
    Comparative Effectiveness, Cost, and Outcomes Research Center, University of Washington, Seattle SDR, BWB, JLF, JGJ Department of Radiology, University of Washington, Seattle SDR, BWB, JGJ Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle BWB, SDS Center for Biomedical Statistics, University of Washington, Seattle PJH, BAC Department of Rehabilitation Medicine, University of Washington, Seattle JLF Departments of Neurological Surgery, Health Services, Pharmacy and Orthopedics and Sports Medicine, University of Washington, Seattle JGJ
    Med Decis Making 34:873-83. 2014
    ..Linking patient-reported back pain outcomes with health utility measures is valuable for informing economic evaluations...
  51. doi request reprint Implementation of a "real-world" learning health care system: Washington State's Comparative Effectiveness Research Translation Network (CERTAIN)
    David R Flum
    University of Washington, Seattle, WA Electronic address
    Surgery 155:860-6. 2014
    ..Most examples of learning systems derive from integrated care delivery systems and examples of such systems in the community at large have been lacking...
  52. ncbi request reprint Emerging therapeutic strategies for asthma management
    Sean D Sullivan
    Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, 1959 NE Pacific Ave, Box 357630, Seattle, WA 98195, USA
    J Manag Care Pharm 9:14-21. 2003
    ..The describe the mechanisms of action of and clinical experience to date with novel asthma drug therapies...
  53. pmc CDR state transition probabilities in Alzheimer's disease with and without cholinesterase inhibitor intervention in an observational cohort
    Lisa M Bloudek
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195 7630, USA
    J Alzheimers Dis 24:599-607. 2011
    ..The NACC-UDS dataset is ongoing and this analysis may be improved if repeated when more data is available...
  54. doi request reprint The impact of using different imputation methods for missing quality of life scores on the estimation of the cost-effectiveness of lung-volume-reduction surgery
    David K Blough
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
    Health Econ 18:91-101. 2009
    ..Owing to the effects of different imputation methods for missing quality of life data on the estimation of the ICER, we recommend use of a minimum of two imputation methods that always include multiple imputation...
  55. ncbi request reprint An economic evaluation of atorvastatin for primary prevention of cardiovascular events in type 2 diabetes
    Scott D Ramsey
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAUniversity of Washington, Seattle, WA 98109, USA
    Pharmacoeconomics 26:329-39. 2008
    ..We estimated the cost effectiveness of atorvastatin as primary prevention against CV disease from the short-term and lifetime US payer perspectives...
  56. ncbi request reprint Characterization of prescribing errors in an internal medicine clinic
    Emily Beth Devine
    Department of Pharmacy, University of Washington UW, Seattle, WA 98195 7630, USA
    Am J Health Syst Pharm 64:1062-70. 2007
    ....
  57. doi request reprint Cost-effectiveness of risk stratification for preventing type 2 diabetes using a multi-marker diabetes risk score
    Sean D Sullivan
    University of Washington, Seattle, WA 98195 7630, USA
    J Med Econ 14:609-16. 2011
    ..The first approach identified high risk patients using impaired fasting glucose (IFG). The second approach used the PreDx Diabetes Risk Score (DRS) to further stratify IFG patients into high-risk and moderate-risk groups...
  58. pmc Cost-effectiveness and population outcomes of general population screening for hepatitis C
    Phillip O Coffin
    Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98104, USA
    Clin Infect Dis 54:1259-71. 2012
    ..Current US guidelines recommend limiting hepatitis C virus (HCV) screening to high-risk individuals, and 50%-75% of infected persons remain unaware of their status...
  59. ncbi request reprint The timing of elective colectomy in diverticulitis: a decision analysis
    Leon Salem
    Department of Surgery, University of Washington, Seattle, WA 98195 6410, USA
    J Am Coll Surg 199:904-12. 2004
    ..We used decision and cost analysis to simulate the clinical and economic outcomes after recovery from an episode of nonsurgically treated diverticulitis to determine the preferable management strategy...
  60. ncbi request reprint Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis C
    Sean D Sullivan
    University of Washington, Seattle, Washington, USA
    Pharmacoeconomics 22:257-65. 2004
    ..The objective of this study was to determine if the gain in SVR with peginterferon alpha-2a plus ribavirin is worth the incremental cost...
  61. doi request reprint Economic consequences of sequencing biologics in rheumatoid arthritis: a systematic review
    Sean D Sullivan
    Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA 98195 7630, USA
    J Med Econ 16:391-6. 2013
    ..However, little is known about whether or not switching to anti-TNF or other non-TNF biologic treatments is cost-effective. This study sought to review the economic evidence of sequencing various biologic treatments in RA...
  62. doi request reprint Estimating the cost-effectiveness of onabotulinumtoxinA for neurogenic detrusor overactivity in the United States
    Josh J Carlson
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
    Clin Ther 35:414-24. 2013
    ..However, the economic impact of onabotulinumtoxinA treatment for UI due to NDO in the United States remains unknown...
  63. doi request reprint Economic costs of nonmedical use of prescription opioids
    Ryan N Hansen
    Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington, USA
    Clin J Pain 27:194-202. 2011
    ....
  64. doi request reprint Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers
    Josh J Carlson
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Box 357630, Seattle, WA, 98195 7630, USA
    Appl Health Econ Health Policy 12:231-8. 2014
    ..The long-term viability and growth of these arrangements will rest in the ability of the parties to develop mutually beneficial arrangements that entail minimal administrative burden in their development and implementation...
  65. doi request reprint Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force
    Sean D Sullivan
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
    Value Health 17:5-14. 2014
    ..Budget impact analyses (BIAs) are an essential part of a comprehensive economic assessment of a health care intervention and are increasingly required by reimbursement authorities as part of a listing or reimbursement submission...
  66. pmc Advanced diagnostic breast cancer imaging: variation and patterns of care in Washington state
    Laura S Gold
    School of Pharmacy, University of Washington School of Public Health, University of Washington Group Health Research Institute, Group Health Cooperative and Fred Hutchinson Cancer Research Center, Seattle, WA
    J Oncol Pract 9:e194-202. 2013
    ....
  67. doi request reprint Level of asthma control and health care utilization in Asia-Pacific countries
    Laura S Gold
    Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA, USA Electronic address
    Respir Med 108:271-7. 2014
    ..This study investigated whether partly- and uncontrolled asthma were associated with increased medication use/healthcare utilization and productivity loss among a population of asthma patients from nine Asia-Pacific countries...